These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23911821)

  • 1. HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.
    Bryant-Hudson KM; Chucair-Elliott AJ; Conrady CD; Cohen A; Zheng M; Carr DJJ
    Am J Pathol; 2013 Oct; 183(4):1233-1242. PubMed ID: 23911821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cornea lymphatics drive the CD8
    Gurung HR; Carr MM; Carr DJ
    Immunol Cell Biol; 2017 Jan; 95(1):87-98. PubMed ID: 27577867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin.
    Royer DJ; Carr DJ
    Mucosal Immunol; 2016 Jul; 9(4):1065-75. PubMed ID: 26627457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice.
    Conrady CD; Thapa M; Wuest T; Carr DJ
    J Immunol; 2009 Mar; 182(6):3678-87. PubMed ID: 19265146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
    Wuest TR; Carr DJ
    J Exp Med; 2010 Jan; 207(1):101-15. PubMed ID: 20026662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.
    Bryant-Hudson KM; Gurung HR; Zheng M; Carr DJ
    J Virol; 2014 Dec; 88(24):14451-7. PubMed ID: 25297992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?
    Bryant-Hudson K; Conrady CD; Carr DJ
    Prog Retin Eye Res; 2013 Sep; 36():281-91. PubMed ID: 23876483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.
    Conrady CD; Halford WP; Carr DJ
    J Virol; 2011 Feb; 85(4):1625-33. PubMed ID: 21147921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.
    Gurung HR; Carr MM; Bryant K; Chucair-Elliott AJ; Carr DJ
    Mucosal Immunol; 2018 Jan; 11(1):172-185. PubMed ID: 28378806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2
    Filiberti A; Gmyrek GB; Berube AN; Carr DJJ
    Front Immunol; 2022; 13():1028341. PubMed ID: 36685562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.
    Austin BA; Halford WP; Williams BR; Carr DJ
    J Immunol; 2007 Apr; 178(8):5166-72. PubMed ID: 17404299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive murine lymph nodes uniquely permit parenchymal access for T cells that enter via the afferent lymphatics.
    Eidsmo L; Stock AT; Heath WR; Bedoui S; Carbone FR
    J Pathol; 2012 Apr; 226(5):806-13. PubMed ID: 22170282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice.
    Zhu J; Dugas-Ford J; Chang M; Purta P; Han KY; Hong YK; Dickinson ME; Rosenblatt MI; Chang JH; Azar DT
    FEBS J; 2015 Apr; 282(8):1458-1467. PubMed ID: 25688651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Regulator Factor 8 (IRF8) Limits Ocular Pathology during HSV-1 Infection by Restraining the Activation and Expansion of CD8+ T Cells.
    Sun L; St Leger AJ; Yu CR; He C; Mahdi RM; Chan CC; Wang H; Morse HC; Egwuagu CE
    PLoS One; 2016; 11(5):e0155420. PubMed ID: 27171004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of Leukocytes.
    Conrady CD; Jones H; Zheng M; Carr DJ
    J Biomed Res; 2011 Mar; 25(2):111-119. PubMed ID: 21709805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
    Harrell MI; Iritani BM; Ruddell A
    Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.